ACRS Aclaris Therapeutics | Upgraded by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.89
+6.3% | $20.00 ➝ $20.00 | Neutral ➝ Buy | |
AMTX Aemetis | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.61
-0.4% | $28.00 ➝ $28.00 | Buy ➝ Buy | |
APLT Applied Therapeutics | Downgraded by | William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Corwin
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $0.84
-4.9% | | Outperform ➝ Market Perform | |
AVXL Anavex Life Sciences | Reiterated by | D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.30
+30.9% | $46.00 ➝ $46.00 | Buy ➝ Buy | |
BBIO BridgeBio Pharma | Target Raised by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.66
+4.4% | $45.00 ➝ $50.00 | Outperform ➝ Outperform | |
BKV BKV | Target Raised by | KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating | T. Rezvan
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $21.77
+0.4% | $23.00 ➝ $25.00 | Overweight ➝ Overweight | |
We recommended Palantir in 2021, now we’re recommending this... (Ad) My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol |
BLK BlackRock | Target Raised by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,037.61
+0.9% | $1,150.00 ➝ $1,200.00 | Buy ➝ Buy | |
BWAY BrainsWay | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.20
-0.4% | $16.00 ➝ $16.00 | Buy ➝ Buy | |
BX Blackstone | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Love
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $172.04
+0.7% | $168.00 ➝ $179.00 | Neutral ➝ Neutral | |
CAE CAE | Upgraded by | Desjardins
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $24.42
+2.7% | | Hold ➝ Buy | |
CAG Conagra Brands | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.27
+0.6% | $33.00 ➝ $32.00 | Overweight ➝ Overweight | |
CASH Pathward Financial | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $73.72
+0.1% | $82.00 ➝ $94.00 | Overweight ➝ Overweight | |
CCL Carnival Co. & | Target Raised by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.76
-3.9% | $30.00 ➝ $31.00 | Buy | |
CCL Carnival Co. & | Target Raised by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.76
-3.9% | $32.00 ➝ $34.00 | Buy ➝ Buy | |
CCL Carnival Co. & | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $25.76
-3.9% | $31.00 ➝ $32.00 | Overweight ➝ Overweight | |
CEVA CEVA | Target Raised by | Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.74
+2.0% | $31.00 ➝ $35.00 | Outperform ➝ Outperform | |
CMPX Compass Therapeutics | Initiated by | D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.49
+8.0% | $32.00 | Buy | |
CSAN Cosan | Reiterated by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.59
-0.5% | $19.00 | Buy | |
DDOG Datadog | Target Raised by | Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | Y. Kim
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $147.66
-1.2% | $160.00 ➝ $200.00 | Buy ➝ Buy | |
DHR Danaher | Initiated by | Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $228.32
-0.1% | $265.00 | Sector Perform | |
DRI Darden Restaurants | Target Raised by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $183.79
-2.0% | $193.00 ➝ $209.00 | Overweight ➝ Overweight | |
ECPG Encore Capital Group | Target Raised by | Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $46.39
-0.9% | $58.00 ➝ $66.00 | Outperform ➝ Outperform | |
EL Estée Lauder Companies | Reiterated by | DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.34
0.0% | $81.00 ➝ $81.00 | Buy ➝ Buy | |
ENFN Enfusion | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.51
-1.1% | $10.00 ➝ $11.50 | Neutral ➝ Neutral | |
ENGN enGene | Initiated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.06
+3.9% | $25.00 | Buy | |
ENGN enGene | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Tuerkcan
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $6.06
+3.9% | $18.00 ➝ $18.00 | Market Outperform ➝ Market Outperform | |
ETWO E2open Parent | Target Lowered by | Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.61
-0.8% | $4.00 ➝ $3.00 | Hold ➝ Hold | |
EVTL Vertical Aerospace | Reiterated by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.46
-5.4% | $16.00 ➝ $16.00 | Buy ➝ Buy | |
EXEL Exelixis | Initiated by | Brookline Capital Management
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.28
0.0% | | Buy | |
FDS FactSet Research Systems | Target Lowered by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $487.47
+0.8% | $521.00 ➝ $518.00 | Market Perform ➝ Market Perform | |
GCMG GCM Grosvenor | Upgraded by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.12
+3.1% | $12.50 ➝ $14.00 | Neutral ➝ Overweight | |
GOOGL Alphabet | Reiterated by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $194.21
+1.5% | $210.00 ➝ $210.00 | Buy ➝ Buy | |
HBAN Huntington Bancshares | Reiterated by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.29
-0.2% | $20.00 ➝ $20.00 | Outperform ➝ Outperform | |
HSY Hershey | Target Lowered by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $168.14
-1.2% | $195.00 ➝ $170.00 | Neutral | |
HUMA Humacyte | Target Raised by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.61
-0.6% | $15.00 ➝ $17.00 | Buy ➝ Buy | |
IIPR Innovative Industrial Properties | Downgraded by | BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $69.97
-5.0% | | Buy ➝ Neutral | |
JSPR Jasper Therapeutics | Reiterated by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.63
+0.3% | $68.00 ➝ $68.00 | Outperform ➝ Outperform | |
KR Kroger | Reiterated by | Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $61.06
-1.3% | $70.00 ➝ $70.00 | Outperform ➝ Outperform | |
KROS Keros Therapeutics | Target Lowered by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.07
+0.2% | $100.00 ➝ $43.00 | Buy ➝ Buy | |
KVYO Klaviyo | Target Raised by | Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $43.16
-2.1% | $45.00 ➝ $60.00 | Buy ➝ Buy | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days.
It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year.
This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now |
LEN Lennar | Target Lowered by | The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Maklari
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $138.41
+0.2% | $190.00 ➝ $162.00 | Neutral ➝ Neutral | |
LGND Ligand Pharmaceuticals | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $116.89
+2.0% | $135.00 ➝ $135.00 | Buy ➝ Buy | |
LW Lamb Weston | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.20
+1.8% | $87.00 ➝ $69.00 | Overweight ➝ Overweight | |
LXRX Lexicon Pharmaceuticals | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.77
+7.6% | | Hold ➝ Hold | |
MESO Mesoblast | Downgraded by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.85
+15.2% | | Buy ➝ Hold | |
MGPI MGP Ingredients | Target Lowered by | Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.56
-1.1% | $65.00 ➝ $60.00 | Buy ➝ Buy | |
MMSI Merit Medical Systems | Reiterated by | Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $97.42
-0.8% | $114.00 ➝ $114.00 | Outperform ➝ Outperform | |
MNDY monday.com | Target Lowered by | Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $232.80
-4.0% | $310.00 ➝ $300.00 | Buy ➝ Buy | |
MSFT Microsoft | Target Raised by | Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $434.63
-0.5% | $500.00 ➝ $550.00 | Buy ➝ Buy | |
MTN Vail Resorts | Reiterated by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $188.28
+2.1% | $197.00 ➝ $197.00 | Equal Weight ➝ Equal Weight | |
NBIX Neurocrine Biosciences | Reiterated by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $136.10
+0.5% | $160.00 ➝ $160.00 | Overweight ➝ Overweight | |
NBIX Neurocrine Biosciences | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $136.10
+0.5% | $160.00 ➝ $165.00 | Overweight ➝ Overweight | |
NFE New Fortress Energy | Target Raised by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.43
+20.7% | $16.00 ➝ $17.00 | Buy ➝ Buy | |
NHI National Health Investors | Target Lowered by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $69.10
-1.1% | $78.00 ➝ $72.00 | Hold ➝ Hold | |
NKE NIKE | Target Lowered by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $76.09
-1.1% | $110.00 ➝ $105.00 | Outperform ➝ Outperform | |
NVO Novo Nordisk A/S | Target Lowered by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $88.45
+4.1% | $156.00 ➝ $105.00 | Outperform ➝ Outperform | |
NWSA News | Target Lowered by | Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.01
+0.5% | $44.00 ➝ $41.00 | Buy ➝ Buy | |
OLLI Ollie's Bargain Outlet | Reiterated by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.53
-0.3% | $130.00 ➝ $130.00 | Outperform ➝ Outperform | |
OLLI Ollie's Bargain Outlet | Target Raised by | Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.53
-0.3% | $120.00 ➝ $130.00 | Buy ➝ Buy | |
OMER Omeros | Initiated by | D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.40
+0.9% | $36.00 | Buy | |
OWL Blue Owl Capital | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.61
+0.5% | $25.00 ➝ $27.00 | Overweight ➝ Overweight | |
PAYX Paychex | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $139.09
-0.3% | $135.00 ➝ $140.00 | Equal Weight ➝ Equal Weight | |
PBYI Puma Biotechnology | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.81
+2.2% | $7.00 ➝ $7.00 | Buy ➝ Buy | |
PCH PotlatchDeltic | Upgraded by | Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.58
+2.1% | $45.00 | Market Perform ➝ Outperform | |
PONY Pony AI | Initiated by | The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.00
+6.4% | $19.60 | Buy | |
PONY Pony AI | Initiated by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.00
+6.4% | $18.00 | Buy | |
REE REE Automotive | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.66
-5.8% | $15.00 ➝ $15.00 | Buy ➝ Buy | |
RMTI Rockwell Medical | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.12
+1.9% | $7.00 ➝ $7.00 | Buy ➝ Buy | |
ROP Roper Technologies | Initiated by | Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $525.62
+0.0% | $630.00 | Outperform | |
RVNC Revance Therapeutics | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | B. Prasad
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $3.08
-0.3% | $7.00 ➝ $3.00 | Equal Weight ➝ Equal Weight | |
RYTM Rhythm Pharmaceuticals | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Selvaraju
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $56.19
+0.1% | $69.00 ➝ $69.00 | Buy ➝ Buy | |
RYTM Rhythm Pharmaceuticals | Reiterated by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Wolleben
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $56.19
+0.1% | $75.00 ➝ $75.00 | Market Outperform ➝ Market Outperform | |
SEIC SEI Investments | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $82.78
+0.0% | $77.00 ➝ $87.00 | Neutral ➝ Neutral | |
SLB Schlumberger | Target Lowered by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.04
+0.6% | $60.00 ➝ $59.00 | Buy ➝ Buy | |
SMTI Sanara MedTech | Initiated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.32
+1.9% | $50.00 | Buy | |
SNOW Snowflake | Target Raised by | Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $161.23
-3.0% | $185.00 ➝ $205.00 | Buy ➝ Buy | |
SOUN SoundHound AI | Target Raised by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.74
-4.7% | $8.00 ➝ $26.00 | Buy ➝ Buy | |
TBBK Bancorp | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $53.20
-0.2% | $61.00 ➝ $64.00 | Overweight ➝ Overweight | |
TBN Tamboran Resources | Reiterated by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Lear
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $17.88
+3.7% | $41.00 ➝ $41.00 | Overweight ➝ Overweight | |
TMO Thermo Fisher Scientific | Initiated by | Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $523.66
-0.1% | $605.00 | Sector Perform | |
TXT Textron | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $76.01
-1.1% | $104.00 ➝ $95.00 | Overweight ➝ Overweight | |
UNIT Uniti Group | Target Raised by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.49
-3.7% | $5.50 ➝ $6.00 | Sector Perform ➝ Sector Perform | |
VNDA Vanda Pharmaceuticals | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Selvaraju
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $4.63
-3.1% | $18.00 ➝ $18.00 | Buy ➝ Buy | |
VRTX Vertex Pharmaceuticals | Target Lowered by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $401.04
+0.9% | $550.00 ➝ $460.00 | Buy ➝ Buy | |
VRTX Vertex Pharmaceuticals | Target Raised by | Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating | G. Harrison
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $401.04
+0.9% | $426.00 ➝ $430.00 | Sector Perform ➝ Sector Perform | |
VRTX Vertex Pharmaceuticals | Target Lowered by | JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $401.04
+0.9% | $503.00 ➝ $500.00 | Overweight ➝ Overweight | |
VYNE VYNE Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.63
+5.2% | $5.75 ➝ $5.75 | Buy ➝ Buy | |
WAT Waters | Initiated by | Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $369.98
+0.5% | $430.00 | Sector Perform | |
WGO Winnebago Industries | Reiterated by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Albanese
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $48.59
-2.8% | $70.00 ➝ $70.00 | Buy ➝ Buy | |
WKSP Worksport | Initiated by | Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.83
-0.7% | $2.00 | Buy | |
No one’s talking about these Trump trades (Ad) As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid.
Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities.
But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.” Go here to see how you can start accessing these opportunities today |
WY Weyerhaeuser | Upgraded by | Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.97
+1.7% | $32.00 | Market Perform ➝ Outperform | |
